Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection
Delphine Planas, Isabelle Staropoli, Françoise Porot, Florence Guivel‐Benhassine, Lynda Handala, Matthieu Prot, William Bolland, Julien Puech, Hélène Péré, David Veyer, Aymeric Sève, Etienne Simon‐Lorière, Timothée Bruel, Thiérry Prazuck, Karl Stéfic, Laurent Hocqueloux, Olivier Schwartz
Topics & Concepts
NeutralizationTiterNeutralizing antibodyVaccinationVirologyAntibodyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineBiologyImmunologyInfectious disease (medical specialty)DiseaseInternal medicineSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesMonoclonal and Polyclonal Antibodies Research